share_log

啓明醫療-B:2024年第二次臨時股東大會之股東代理人委任表格

VENUS MEDTECH-B: PROXY FORMFOR USE AT THE 2024 SECOND EXTRAORDINARY GENERAL MEETING

HKEX ·  Nov 19, 2024 17:04

Summary by Futu AI

啟明醫療-B將於2024年12月5日舉行2024年第二次臨時股東大會,地點為中國杭州濱江區。會議將審議包括選舉古軍華先生為獨立非執行董事在內的多項決議案。此外,股東將就修訂公司章程相關條款及授予董事會發行股份的一般性授權等事宜進行投票。股東代理人委任表格顯示,股東可委任代理人出席大會並代表其投票,而所有投票事宜均需於大會指定舉行時間的24小時前完成相關委任手續。
啟明醫療-B將於2024年12月5日舉行2024年第二次臨時股東大會,地點為中國杭州濱江區。會議將審議包括選舉古軍華先生為獨立非執行董事在內的多項決議案。此外,股東將就修訂公司章程相關條款及授予董事會發行股份的一般性授權等事宜進行投票。股東代理人委任表格顯示,股東可委任代理人出席大會並代表其投票,而所有投票事宜均需於大會指定舉行時間的24小時前完成相關委任手續。
Qiming Medical-B will hold the second extraordinary general meeting of shareholders for 2024 on December 5, 2024, at the Binjiang District in Hangzhou, China. The meeting will discuss multiple resolutions, including the election of Mr. Gu Junhua as an independent non-executive director. In addition, shareholders will vote on matters related to amending relevant provisions of the company’s articles of association and granting the board of directors general authority to issue shares. The shareholder proxy appointment form indicates that shareholders can appoint a proxy to attend the meeting and vote on their behalf, while all voting matters must be completed 24 hours before the scheduled time of the meeting.
Qiming Medical-B will hold the second extraordinary general meeting of shareholders for 2024 on December 5, 2024, at the Binjiang District in Hangzhou, China. The meeting will discuss multiple resolutions, including the election of Mr. Gu Junhua as an independent non-executive director. In addition, shareholders will vote on matters related to amending relevant provisions of the company’s articles of association and granting the board of directors general authority to issue shares. The shareholder proxy appointment form indicates that shareholders can appoint a proxy to attend the meeting and vote on their behalf, while all voting matters must be completed 24 hours before the scheduled time of the meeting.

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.